11Lite, a startup operating "Lifepet," a total pet health care solution, has secured pre-Series A bridge investment from Korea Technology Finance Corporation and AC Pathfinder. This investment brings 11Lite's total funding to over 2 billion won.
11Liter's core competitive edge lies in its proprietary AI technology, which can identify the presence and severity of a pet's progressive disease in just three seconds using a smartphone photo. In particular, its patellar luxation diagnostic assistance software achieved a sensitivity of 97.6% and a specificity of 98.8% in clinical trials, becoming Korea's first veterinary medical device (Class 3) approval. The related research was published in the SCI-level international academic journal "Scientific Reports."
Currently, Lifepet provides analysis services for major diseases such as patellar dislocation, periodontal disease, obesity, and cataracts, with a cumulative total of 170,000 analyses and 80,000 members. Based on its technological prowess, 11Lite plans to participate in the global stage through the Samsung Electronics C-Lab exhibition hall at CES in January 2026.
Sipilliter provides its AI health check technology to major partners, including smartphone manufacturers, home appliance manufacturers, insurance companies, and telecommunications companies, through a modularized API. "Lypet Pet Insurance," jointly launched with DB Insurance, is known as the first domestic example of offering premium discounts based on AI analysis results. Furthermore, it is building a pet home care ecosystem by offering over 1,000 customized health management products and integrated pet insurance services that cover treatment costs.
“This investment is a recognition that AI technology is driving real innovation across the pet industry,” said Kim Gwang-hyun, CEO of 11Liter. “In 2026, we will expand collaboration with global partners and aggressively increase our market share.”
- See more related articles
You must be logged in to post a comment.